Abstract
Background:
The co-occurrence of multiple sclerosis (MS) and cervical spondylosis (CS) may not only intensify symptoms but also complicate the management of these disorders. Magnetic resonance imaging (MRI) is the preferred modality for detecting spinal cord lesions; however, there is limited evidence assessing myelopathy in concurrent CS and MS.Objectives:
This study aims to evaluate the association between CS and its effects on the spinal cord, as well as their impact on enhancing MS cervical lesions.Methods:
This cross-sectional study was conducted on 104 MS patients between 2019 and 2021. Data collected included age, gender, duration and phenotype of MS, and the Extended Disability Status Scale (EDSS). Magnetic resonance imaging images were obtained and analyzed for the presence of cervical spondylosis and demyelinated cervical plaques (active/inactive). Multiple sclerosis plaques were evaluated based on their extension, enhancement, and cervical location. Cervical spondylosis was categorized into four grades using the Muhle scale. Additionally, the spinal cord cross-sectional area (SC - CSA) was measured at the C2 - C3 cervical spine level.Results:
The severity of cervical spondylosis was associated with older age (P-value < 0.001), longer duration of MS (P-value = 0.04), more severe EDSS scores (P-value = 0.03), and a lower C2 - C3 CS-CSA (P-value < 0.001). However, no significant associations were found with gender (P-value = 0.90), MS plaques activity (P-value = 0.25), or extension (P-value = 0.13).Conclusions:
The study findings indicate that the severity of CS is associated with age, MS duration, EDSS, and the C2 - C3 cervical spine cross-sectional area. However, the study did not find evidence supporting a relationship between CS and the extension or activity of MS plaques.Keywords
Magnetic Resonance Imaging Multiple Sclerosis Spondylosis Cervical Cord
1. Background
Multiple sclerosis (MS) is a chronic, disabling neuroinflammatory demyelinating disease affecting the central nervous system. This disorder primarily manifests in young adults and causes a range of sensory, motor, and cognitive impairments (1, 2). Although MS often begins in youth, its symptoms can persist for a lifetime, making it a long-term condition that significantly impacts patients over many years (3). Typically, MS presents as a remitting-relapsing course characterized by inflammatory demyelination and neurological disability resulting from axonal damage (4). However, other MS phenotypes can include progressive clinical disability, with or without periods of relapse and remission (5). The presence of demyelinated lesions below the level of the cerebellar tentorium and involvement of the spinal canal can lead to increased disability in MS patients (6).
Cervical spondylosis (CS) is a common age-related condition with a chronic and progressive nature that affects the bone and cartilage of the cervical vertebrae (7). The cervical spinal structures, including bones, intervertebral discs, facets, and ligaments, are most commonly involved in CS (8). Severe cases of CS can exert pressure on the spinal cord and result in associated myelopathy. Although degenerative changes can occur at any age, they are not always symptomatic (9). Mechanical forces caused by cervical spondylosis contribute to local neuroinflammation by increasing the vascular permeability of the spinal blood barrier, which, over time, leads to apoptotic responses in neurons and oligodendrocytes (10, 11).
Symptoms related to cord compression due to CS can resemble those of MS and include spasticity, gait incontinence, sensory deficits, weakness in the lower and/or upper extremities, gastrointestinal and genitourinary dysfunction, Lhermitte's sign, and pain in the upper limbs or neck (12). The concurrent presence of MS and CS presents a challenge for neurologists and neurosurgeons in diagnosing, treating, and managing the conditions. There is often uncertainty about which disease is the primary cause and concern that spinal manipulation may trigger an MS relapse or exacerbation (13).
The issue of the association between MS and CS and their impact on each other was first explored by Brain and Wilkinson in 1957, who questioned whether the clinical characteristics of MS are affected by cervical cord compression due to degenerative changes. To address this question, they performed autopsies on only two patients, finding that the sites of demyelination were associated with the presence of spondylotic bars. They suggested that these bars might have had a compressive effect on the cord, leading to impaired blood supply. Therefore, both spondylotic changes and demyelinating plaques might have a reciprocal role. However, they concluded that further investigation was needed for a more definitive answer (14).
Twenty years later, neuropathologist Oppenheimer examined the spinal cords of 18 MS patients and found no association between plaque locations and degenerative changes. Instead, he noted that spondylotic lesions were typically fan-shaped and located in the lateral columns. Oppenheimer hypothesized that "mechanical stresses" might contribute to plaque formation due to the impact of fibrous adhesions on the dura, rather than compressive effects (15).
The key question remains: Can decompressive interventions reduce plaque formation and MS symptoms? Data on this topic are controversial. While it has been shown that carefully selected MS patients could benefit from decompressive surgery, comparisons with healthy individuals did not reveal significant differences (16, 17).
Magnetic resonance imaging (MRI) is the preferred method for assessing cord lesions in MS. Limited evidence is available on the association between myelopathy due to cord compression in CS and the deterioration or progression of MS lesions (5, 12, 18). Despite these efforts, previous studies have not utilized MRI with contrast to enhance the visualization of lesions.
2. Objectives
The current study aims to assess the association between CS and its effects on the spinal cord with enhanced MS cervical lesions.
3. Methods
3.1. Study Population
The current retrospective cross-sectional study was conducted on 104 MS patients with concurrent cervical spondylosis who were referred to outpatient MS clinics affiliated with Isfahan University of Medical Sciences from January 2019 to March 2021.
The study protocol adhered to the principles of the Helsinki Declaration, was submitted to the Ethics Committee of Isfahan University of Medical Sciences, and was approved under code number IR.MUI.MED.REC.1399.1167. Patients were informed about the potential use of their medical data for scientific research, assured of the confidentiality of their personal information, and provided written consent.
Patients over eighteen years old with a documented diagnosis of multiple sclerosis based on McDonald Criteria 2017 (19), who underwent both enhanced and unenhanced cervical MRI during the study period and had an active medical record in the referral MS clinics, were included. Exclusion criteria included having more than 20% missing data in medical records, a history of spinal surgery, or the presence of other pathologies such as congenital spinal deformities, spinal tumors, cervical vertebrae fractures, or spinal cord trauma (17).
The study population was selected through convenience sampling. All MRI images were interpreted by a panel consisting of two neuroradiologists and one neurologist, all of whom are experts in neuroimaging interpretation.
3.2. Data Collection
The retrieved demographic and medical data of the patients included age at disease onset, gender, MS phenotype (remitting-relapsing MS (RRMS), primary progressive MS (PPMS), secondary progressive MS (SPMS), and progressive-relapsing MS (PRMS)) (20), disease duration, medication history, and the Extended Disability Status Scale (EDSS) (21) at the time of the study.
The MRI images were acquired using a 1.5 Tesla MRI, following the MS Centers' consensus 2019 guidelines. Gadolinium-based contrast (287 mg/mL) was administered intravenously at a dosage of 0.1 mmol/kg for 30 seconds, and imaging was performed within the subsequent 5 minutes (22). Table 1 presents the MRI protocols used in the current study (23).
The Characteristics of Magnetic Resonance Imaging of the Spinal Cord
The images were interpreted to identify the presence of cervical spondylosis and demyelinated cervical plaques (active or inactive). Cervical spondylosis was categorized into 4 grades using the Muhle scale (Table 2) (24).
Muhle Grading System for Cervical Spondylosis
| Grade | Definition |
|---|---|
| 0 | Normal spinal canal diameter, without anterior or posterior subarachnoid space stenosis |
| I | Incomplete obliteration of the anterior or posterior subarachnoid space or both |
| II | Complete obliteration of the anterior or posterior subarachnoid space or both |
| III | Compressive effect on the spinal cord anteriorly or posteriorly or both |
The MS plaques were evaluated in terms of extension, enhancement, and cervical plane. Spinal cord lesion extension was categorized as: No spinal plaque, solitary cervical plaque, multiple non-contiguous spinal plaques, and multiple contiguous spinal plaques. The plaques were classified as either enhanced (active) or non-enhanced (inactive). Additionally, the spinal cord cross-sectional area (SC - CSA) was measured at the C2 - C3 cervical spine level (25).
Figure 1 illustrates the process of the study.
The study protocol
3.3. Statistical Analysis
The obtained data were entered into the Statistical Package for Social Sciences (version 20, IBM Corporation, Armonk, NY). Descriptive statistics were presented as means, standard deviations, absolute numbers, and percentages. The independent t-test or one-way ANOVA test was used to compare continuous data. Categorical information was compared using the chi-square test or Fisher’s exact test. A P-value of 0.05 was considered the level of significance.
4. Results
The current investigation was conducted on 104 MS patients with a mean age of 34.8 ± 7.9 years (range: 18 - 56 years). The study population predominantly consisted of females (n = 69, 66.3%). The Muhle grading system revealed that most patients had cervical spinal cord alignment within the physiological range (40.4%), followed by grades 1 (27.9%) and 2 (20.2%) (Table 3).
The Demographic and Clinical Characteristics of the Studied Population a
| Variables | Measurement |
|---|---|
| Age (y) | 34.8 ± 7.9 |
| Duration of the disease (y) | 4.6 ± 0.3 |
| Extended Disability Status Scale | 1.8 ± 0.1 |
| Gender | |
| Male | 69 (66.3) |
| Female | 35 (33.7) |
| Muhle cervical spondylosis grading | |
| 0 | 42 (40.4) |
| I | 29 (27.9) |
| II | 21 (20.2) |
| III | 12 (11.5) |
Table 4 demonstrates the association of SC grading with various demographic and clinical categories.
Association of Cervical Spondylosis Grading with Diverse Demographic and Clinical Categories
| Variables | 0 | I | II | III | P-Value |
|---|---|---|---|---|---|
| Age (y) | 30.4 ± 6.7 | 34.03 ± 6.2 | 39.1 ± 6.4 | 44.4 ± 6.6 | < 0.001 |
| Disease duration (y) | 3.9 ± 0.5 | 4.3 ± 0.7 | 5.4 ± 0.8 | 6.05 ± 1.1 | 0.04 |
| EDSS | 1.5 ± 0.2 | 1.8 ± 0.3 | 2 ± 0.3 | 2.3 ± 0.4 | 0.03 |
| Gender | 0.90 | ||||
| Male | 14 (33.3) | 10 (34.5) | 6 (28.6) | 5 (41.7) | |
| Female | 28 (66.7) | 19 (65.5) | 15 (71.4) | 7 (58.3) | |
| Plaque extension | 0.13 | ||||
| Without spinal plaque | 17 (40.5) | 11 (37.9) | 7 (33.3) | 3 (25) | |
| Solitary cervical plaque | 16 (38.1) | 11 (37.9) | 6 (28.6) | 4 (33.3) | |
| Multiple non-contiguous spinal plaques | 6 (14.3) | 5 (17.3) | 5 (23.8) | 3 (25) | |
| Multiple contiguous spinal plaques | 3 (7.1) | 2 (6.9) | 3 (14.3) | 2 (16.7) | |
| Enhancement pattern | 0.25 | ||||
| Enhanced (active plaque) | 4 (18.2) | 3 (15.8) | 4 (28.6) | 3 (37.5) | |
| Unenhanced (inactive plaque) | 18 (81.8) | 16 (84.2) | 10 (71.4) | 5 (62.5) | |
| C2 - C3 level cross-sectional area (mm2) | 73.8 ± 3.4 | 72.7 ± 3.7 | 71.7 ± 3.8 | 68.5 ± 3.7 | < 0.001 |
5. Discussion
However, although spondylosis can begin at any age, it is generally associated with aging (26). Consequently, potential compression on the spinal cord can adversely affect patients with multiple sclerosis (27). In the current study, we investigated factors related to the severity of cervical spondylosis in MS patients and found that older age, longer duration of MS, worse EDSS scores, and a smaller C2 - C3 cervical level cross-sectional area were associated with more severe spondylosis. However, other characteristics, including gender, the extension of MS plaques, and the activity of the plaques, did not show any correlation with the severity of spondylosis.
Given the nature of spondylosis, it is not surprising to find a direct association between patients' age and the severity of cervical spondylosis. Literature consistently shows greater progression of spondylosis among older individuals compared to younger ones, regardless of whether they have a disease (9, 28, 29). In agreement with our findings, Bomprezzi et al. also reported more severe spondylosis among older MS patients (18).
The current study also revealed that patients with a longer duration of MS and more severe disabilities based on the EDSS experienced more severe cervical spondylosis. Consistent with these findings, another study on MS patients with cervical spine degenerative disorders showed that those with exacerbated MS symptoms had worse manifestations of spondylosis, including disc degeneration, posterior disc protrusion, endplate changes, and canal and foraminal stenosis (30). These results were supported by other studies (16, 17). We hypothesize that these findings may be due to the higher age of these patients, who are potentially at increased risk for cervical degenerative disorders. However, patients with longer MS duration and more severe EDSS scores might experience more severe MS-related disabilities, which could lead to chronic positioning in inappropriate alignments to alleviate pain or compensate for disabilities. This chronic positioning might accelerate the development of spondylosis over time (17, 31). Additionally, researchers have suggested that reduced exercise tolerance, a high Body Mass Index, and reduced core muscle strength, along with excessive or non-mechanical pressure on the spinal column, can cause abnormal posture and loss of normal spinal curvature (32, 33). Furthermore, Chhugani et al. identified suboptimal bone health and vitamin D deficiency in MS patients as factors contributing to the exacerbation of cervical spondylosis. They suggested that the inflammatory nature of MS may trigger the early onset or accelerate the progression of degenerative disease, indicating a bidirectional association where each condition might worsen the other (30). However, Bomprezzi et al. did not find an association between EDSS and cervical spondylosis, even after adjusting for age, gender, disease duration, and MS phenotype (18). Similarly, Alkrenawi et al., in their assessment of discopathy in MS patients, reported no association between MS symptoms and the severity of cervical disc degeneration (34).
Another expected result of the current study showed an inverse association between the area of the cervical cord at the C2 - C3 level and the severity of spondylosis. Similar outcomes have been reported in the literature, as more severe spondylosis is potentially associated with canal and foraminal stenosis (30). Gratch et al. even suggested that as cervical spondylosis progresses, the interrupted blood supply to the cord could potentially cause MS lesion progression. They proposed that the increased pressure from nearby tissues might play a role in the pathogenesis of MS. However, they also noted that cervical spondylosis is not the sole factor contributing to the pathogenesis of MS (17).
Despite these findings, we found no relation between MS plaque extension or activity and the severity of cervical spondylosis. Data from other studies on this topic are controversial. Ocak et al. reported that discopathy was associated with MS plaque formation by generating microtraumas that disrupt the blood-brain barrier (5). Conversely, Gratch et al. found that segments with at least moderate cervical spondylosis were significantly associated with the presence of MS lesions in the same segment (17). Other studies have proposed that repetitive trauma at the site of stenosis leads to the breakdown of the blood-spinal cord barrier, allowing immune cells to invade the central nervous system and contribute to plaque formation (18, 35). Compromised blood supply to the blood-spinal cord barrier due to recurrent mechanical forces may contribute to neuroinflammation, another mechanism by which MS lesions might form (11, 17). Additionally, atrophy due to continuous pressure on the cord, friction, or traction on the affected spinal cord portion might worsen MS disabilities, not only impairing blood supply but also affecting the functions surviving from MS activities (36, 37).
Although, to the best of our knowledge, the current study is the only one using contrast to assess the association between MS plaque activity and the severity of, our findings were inconsistent with the hypothesized relationship. This discrepancy might be due to the larger sample size or a failure to control for potential confounding variables affecting CS severity, MS symptoms, clinical manifestations, or neuroimaging characteristics.
5.1. Conclusions
Based on the findings of this study, the severity of CS was associated with age, duration of MS, EDSS, and the C2 - C3 cervical spine cross-sectional area. However, there was no observed relationship between CS and the extension or activity of MS plaques. Although the interactions between MS and CS, as well as approaches for their management, have long been a topic of investigation with ongoing controversies, further research is needed to enhance our understanding and guide decisions on surgical versus conservative management for these patients.
Acknowledgements
References
-
1.
do Amaral LLF, Fragoso DC, Nunes RH, Littig IA, da Rocha AJ. Gadolinium-Enhanced Susceptibility-Weighted Imaging in Multiple Sclerosis: Optimizing the Recognition of Active Plaques for Different Mr Imaging Sequences. AJNR Am J Neuroradiol. 2019;40(4):614-9. [PubMed ID: 30846435]. [PubMed Central ID: PMC7048498]. https://doi.org/10.3174/ajnr.A5997.
-
2.
Schoonheim MM, Geurts JJG. What Causes Deep Gray Matter Atrophy In Multiple Sclerosis? AJNR Am J Neuroradiol. 2019;40(1):107-8. [PubMed ID: 30591510]. [PubMed Central ID: PMC7048614]. https://doi.org/10.3174/ajnr.A5942.
-
3.
Zanghi A, D'Amico E, Patti F. Immunosuppression in Relapsing Remitting Multiple Sclerosis: Moving Towards Personalized Treatment. Expert Rev Neurother. 2020;20(8):771-82. [PubMed ID: 31971026]. https://doi.org/10.1080/14737175.2020.1721282.
-
4.
Marin CE, Callegaro D, Lana-Peixoto MA, Fernandez O, Gomes Neto AP, Vasconcelos CCF, et al. Evaluation of Diagnosis and Treatment Practices of Brazilian Neurologists Among Patients With Multiple Sclerosis. Arq Neuropsiquiatr. 2021;79(7):598-606. [PubMed ID: 34468497]. https://doi.org/10.1590/0004-282X-ANP-2020-0362.
-
5.
Ocak O, Cetiner M, Zorlu Y, Sener U, Uygur M. The Relation Between Cervical and Thoracal Disc Herniations and Multiple Sclerosis Plaques: A Retrospective Review. Med Sci. 2017;6(4). https://doi.org/10.5455/medscience.2017.06.8632.
-
6.
Brownlee WJ, Altmann DR, Alves Da Mota P, Swanton JK, Miszkiel KA, Wheeler-Kingshott CG, et al. Association of Asymptomatic Spinal Cord Lesions and Atrophy With Disability 5 Years After a Clinically Isolated Syndrome. Mult Scler. 2017;23(5):665-74. [PubMed ID: 27481210]. https://doi.org/10.1177/1352458516663034.
-
7.
Theodore N. Degenerative Cervical Spondylosis. N Engl J Med. 2020;383(2):159-68. [PubMed ID: 32640134]. https://doi.org/10.1056/NEJMra2003558.
-
8.
Umeria R, Mowforth O, Grodzinski B, Karimi Z, Sadler I, Wood H, et al. A Scoping Review of Information Provided Within Degenerative Cervical Myelopathy Education Resources: Towards Enhancing Shared Decision Making. PLoS One. 2022;17(5). e0268220. [PubMed ID: 35588126]. [PubMed Central ID: PMC9119544]. https://doi.org/10.1371/journal.pone.0268220.
-
9.
Kuo DT, Tadi P. Cervical Spondylosis. StatPearls [Internet]. Treasure, Island: StatPearls; 2019.
-
10.
Yu WR, Liu T, Kiehl TR, Fehlings MG. Human Neuropathological and Animal Model Evidence Supporting a Role For Fas-Mediated Apoptosis and Inflammation in Cervical Spondylotic Myelopathy. Brain. 2011;134(Pt 5):1277-92. [PubMed ID: 21490053]. https://doi.org/10.1093/brain/awr054.
-
11.
Murphy OC, Salazar-Camelo A, Jimenez JA, Barreras P, Reyes MI, Garcia MA, et al. Clinical and MRI Phenotypes of Sarcoidosis-Associated Myelopathy. Neurol Neuroimmunol Neuroinflamm. 2020;7(4). [PubMed ID: 32269072]. [PubMed Central ID: PMC7176244]. https://doi.org/10.1212/NXI.0000000000000722.
-
12.
Badhiwala JH, Ahuja CS, Akbar MA, Witiw CD, Nassiri F, Furlan JC, et al. Degenerative Cervical Myelopathy - Update and Future Directions. Nat Rev Neurol. 2020;16(2):108-24. [PubMed ID: 31974455]. https://doi.org/10.1038/s41582-019-0303-0.
-
13.
Mohr DC, Hart SL, Julian L, Cox D, Pelletier D. Association Between Stressful Life Events and Exacerbation in Multiple Sclerosis: A Meta-Analysis. BMJ. 2004;328(7442):731. [PubMed ID: 15033880]. [PubMed Central ID: PMC381319]. https://doi.org/10.1136/bmj.38041.724421.55.
-
14.
Brain R, Wilkinson M. The Association of Cervical Spondylosis and Disseminated Sclerosis. Brain. 1957;80(4):456-78. [PubMed ID: 13499755]. https://doi.org/10.1093/brain/80.4.456.
-
15.
Oppenheimer DR. The Cervical Cord in Multiple Sclerosis. Neuropathol Appl Neurobiol. 1978;4(2):151-62. [PubMed ID: 683462]. https://doi.org/10.1111/j.1365-2990.1978.tb00555.x.
-
16.
Purvis TE, Lubelski D, Mroz TE. Is Decompressive Surgery for Cervical Spondylotic Myelopathy Effective in Patients Suffering From Concomitant Multiple Sclerosis or Parkinson's Disease? Brain Sci. 2017;7(4). [PubMed ID: 28394266]. [PubMed Central ID: PMC5406696]. https://doi.org/10.3390/brainsci7040039.
-
17.
Gratch D, Do D, Khankhanian P, Schindler M, Schmitt JE, Berger JR. Impact of Cervical Stenosis on Multiple Sclerosis Lesion Distribution in the Spinal Cord. Mult Scler Relat Disord. 2020;45:102415. [PubMed ID: 32717683]. [PubMed Central ID: PMC7978144]. https://doi.org/10.1016/j.msard.2020.102415.
-
18.
Bomprezzi R, Chen AP, Hemond CC. Cervical Spondylosis is a Risk Factor for Localized Spinal Cord Lesions in Multiple Sclerosis. Clin Neurol Neurosurg. 2020;199:106311. [PubMed ID: 33091657]. https://doi.org/10.1016/j.clineuro.2020.106311.
-
19.
Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, et al. Diagnosis of Multiple Sclerosis: 2017 Revisions of the Mcdonald Criteria. Lancet Neurol. 2018;17(2):162-73. [PubMed ID: 29275977]. https://doi.org/10.1016/S1474-4422(17)30470-2.
-
20.
Goldenberg MM. Multiple Sclerosis Review. Pharm Therapeut. 2012;37(3):175-84. [PubMed ID: 22605909]. [PubMed Central ID: PMC3351877].
-
21.
Meyer-Moock S, Feng YS, Maeurer M, Dippel FW, Kohlmann T. Systematic Literature Review and Validity Evaluation of the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Functional Composite (MSFC) in Patients With Multiple Sclerosis. BMC Neurol. 2014;14:58. [PubMed ID: 24666846]. [PubMed Central ID: PMC3986942]. https://doi.org/10.1186/1471-2377-14-58.
-
22.
Arevalo O, Riascos R, Rabiei P, Kamali A, Nelson F. Standardizing Magnetic Resonance Imaging Protocols, Requisitions, and Reports in Multiple Sclerosis: An Update for Radiologist Based on 2017 Magnetic Resonance Imaging in Multiple Sclerosis and 2018 Consortium of Multiple Sclerosis Centers Consensus Guidelines. J Comput Assist Tomogr. 2019;43(1):1-12. [PubMed ID: 30015803]. https://doi.org/10.1097/RCT.0000000000000767.
-
23.
Simon JH, Li D, Traboulsee A, Coyle PK, Arnold DL, Barkhof F, et al. Standardized MR Imaging Protocol for Multiple Sclerosis: Consortium of MS Centers Consensus Guidelines. AJNR Am J Neuroradiol. 2006;27(2):455-61. [PubMed ID: 16484429]. [PubMed Central ID: PMC8148806].
-
24.
Muhle C, Metzner J, Weinert D, Falliner A, Brinkmann G, Mehdorn MH, et al. Classification System Based on Kinematic MR Imaging in Cervical Spondylitic Myelopathy. AJNR Am J Neuroradiol. 1998;19(9):1763-71. [PubMed ID: 9802503]. [PubMed Central ID: PMC8337474].
-
25.
Casserly C, Seyman EE, Alcaide-Leon P, Guenette M, Lyons C, Sankar S, et al. Spinal Cord Atrophy in Multiple Sclerosis: A Systematic Review and Meta-Analysis. J Neuroimaging. 2018;28(6):556-86. [PubMed ID: 30102003]. https://doi.org/10.1111/jon.12553.
-
26.
McCormick JR, Sama AJ, Schiller NC, Butler AJ, Donnally C3. Cervical Spondylotic Myelopathy: A Guide to Diagnosis and Management. J Am Board Fam Med. 2020;33(2):303-13. [PubMed ID: 32179614]. https://doi.org/10.3122/jabfm.2020.02.190195.
-
27.
Shedid D, Benzel EC. Cervical Spondylosis Anatomy: Pathophysiology and Biomechanics. Neurosurgery. 2007;60(1 Supp1 1):S7-13. [PubMed ID: 17204889]. https://doi.org/10.1227/01.NEU.0000215430.86569.C4.
-
28.
Alzayer MI, Alnamazi NAA, Alsaleh AAA, Buarish SE, Alhammad WIA, Alhammad SIA, et al. A Review on Diagnosis and Management of Cervical Spondylosis. J Pharm Res Int. 2021:668-74. https://doi.org/10.9734/jpri/2021/v33i47A33059.
-
29.
Lv Y, Tian W, Chen D, Liu Y, Wang L, Duan F. The Prevalence and Associated Factors of Symptomatic Cervical Spondylosis In Chinese Adults: A Community-Based Cross-Sectional Study. BMC Musculoskelet Disord. 2018;19(1):325. [PubMed ID: 30205836]. [PubMed Central ID: PMC6134586]. https://doi.org/10.1186/s12891-018-2234-0.
-
30.
Chhugani S, Agarwal N, Sheikh F, Borca F, Spanoulis A, Galea I. Cervical Spinal Degenerative Disease in Multiple Sclerosis. Eur J Neurol. 2021;28(8):2497-502. [PubMed ID: 33817913]. https://doi.org/10.1111/ene.14855.
-
31.
Owiti W, Peev N, Arif S, Brady Z, AbdelHafiz T. Is Surgery Beneficial for Patients With Concurrent Multiple Sclerosis and Degenerative Cervical Myelopathy? A Review af Literature. Brain Spine. 2022;2:100870. [PubMed ID: 36248132]. [PubMed Central ID: PMC9560582]. https://doi.org/10.1016/j.bas.2022.100870.
-
32.
Xydis VG, Zikou AK, Kostadima V, Astrakas LG, Kosta P, Argyropoulou MI. The Association Between Multiple Sclerosis and Spondylosis: When and Why. Eur J Radiol. 2017;91:47-51. [PubMed ID: 28629570]. https://doi.org/10.1016/j.ejrad.2017.03.017.
-
33.
Yoosefinejad AK, Motealleh A, Khademi S, Hosseini SF. Lower Endurance and Strength of Core Muscles in Patients With Multiple Sclerosis. Int J MS Care. 2017;19(2):100-4. [PubMed ID: 32607068]. [PubMed Central ID: PMC7313410]. https://doi.org/10.7224/1537-2073.2015-064.
-
34.
Alkrenawi M, Osherov M, Simonovich A, Droujin J, Milo R, Appel S. Association Between Cervical Disc Disease and Lesions of Multiple Sclerosis. Neuroradiol J. 2021;34(3):200-4. [PubMed ID: 33393859]. [PubMed Central ID: PMC8165899]. https://doi.org/10.1177/1971400920983565.
-
35.
Spencer JI, Bell JS, DeLuca GC. Vascular Pathology in Multiple Sclerosis: Reframing Pathogenesis Around the Blood-Brain Barrier. J Neurol Neurosurg Psychiatry. 2018;89(1):42-52. [PubMed ID: 28860328]. https://doi.org/10.1136/jnnp-2017-316011.
-
36.
Bussas M, El Husseini M, Harabacz L, Pineker V, Grahl S, Pongratz V, et al. Multiple Sclerosis Lesions and Atrophy in the Spinal Cord: Distribution Across Vertebral Levels and Correlation With Disability. Neuroimage Clin. 2022;34:103006. [PubMed ID: 35468568]. [PubMed Central ID: PMC9059154]. https://doi.org/10.1016/j.nicl.2022.103006.
-
37.
Barbagallo GM, Marshman LA, Hardwidge C, Gullan RW. Thoracic Idiopathic Spinal Cord Herniation at the Vertebral Body Level: A Subgroup With a Poor Prognosis? Case Reports and Review of the Literature. J Neurosurg. 2002;97(3 Suppl):369-74. [PubMed ID: 12408396]. https://doi.org/10.3171/spi.2002.97.3.0369.